Covid-19 Impact On Preclinical Imaging Market 2020, Global Trends, Technology Advancement, Industry Size, Growth, Top Companies, Opportunities, Outlook

Preclinical Imaging Market Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) - Global Forecast Till 2023

Preclinical Imaging Market Insight

The global preclinical imaging market is growing pervasively, witnessing increasing consumption of imaging products in various modalities. Also, rising technological advances in the field of molecular imaging, alongside the growing demand for non-invasive small animal imaging techniques drives the growth of the market. Moreover, increasing funding to support preclinical researches is escalating the market growth to furthered height.

According to Market Research Future (MRFR), the global preclinical imaging market valuation had reached USD 2.01 BN in 2017, which is further expected to appreciate at 6.3% CAGR over the assessment period (2018 to 2023). The market has seen several innovative and easy-to-use imaging agents launches, which has undoubtedly helped in the growth of the market. Rising technological advancements are estimated to propel the growth of the market.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @

The growing prevalence of myriads of chronic diseases and increasing awareness about the innovative diagnostics methods that can offer early diagnosis benefits influence the growth of the market. Additionally, high R&D investments made in the development of efficient imaging solutions are estimated to foster the growth of the market throughout the review period.

On the other hand, strict regulations in preclinical research are projected to obstruct the growth of the market in the years to come. Also, high costs associated with installation and operational costs associated with preclinical imaging modalities are likely to hamper the market growth. Nevertheless, increasing applications of preclinical imaging products in life sciences research would support the growth of the market throughout the predicted period.

Preclinical Imaging Market - Segments

The analysis is segmented into three dynamics.

By Modality: Optical Imaging Systems (Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, Optical + X-ray/ Optical + CT systems, others), Nuclear Imaging Systems (Micro-PET Systems, Micro-Spect Systems, Trimodality (Spect/PET/CT) Systems, others), Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System, Magnetic Particle Imaging Systems, and others.

By Reagent: Preclinical Optical Imaging Reagents (Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents, others), Preclinical Nuclear Imaging Reagents (Preclinical PET Tracers, Preclinical Spect Probes, others), Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents, and others.

By Regions: Europe, Americas, Asia Pacific, and Rest-of-the-World.

Preclinical Imaging Market - Regional Analysis

North America leads the global preclinical imaging market. The largest market share is attributed to the presence of several industry players and technological advancements in molecular imaging in the region. Besides, factors such as the increasing market demand for non-invasive small animal imaging techniques and increasing funding to support preclinical researches foster the regional market growth.

Additionally, well-established healthcare sectors in the region, alongside the rising healthcare spending and adoption of preclinical imaging in medical diagnostics, spur the growth of the market. The US and Canada are major markets for preclinical imaging, which contribute significantly to the market growth in North America. The North American preclinical imaging market is estimated to continue its dominance over the global market throughout the forecast period.

Europe stands second in the global preclinical imaging market. The market growth is driven by the increasing funding to support preclinical researches from regulatory authorities in the diagnosis of various chronic diseases. Moreover, augmenting demand for innovative & easy to use imaging agents in the medical sector has been increasing the size of the market. Furthermore, growing healthcare expenses, the resurging economy in the region, and spreading awareness about preclinical imaging modalities positively impact the regional market.

The Asia Pacific preclinical imaging market is growing rapidly. Factors such as rising numbers of biotechnology and pharmaceutical companies increase the size of the preclinical imaging market excellently. Besides, the growing penetration of imaging technology in the healthcare sector for medical imaging purposes fosters regional market growth. The APAC preclinical imaging market is projected to create a substantial revenue pocket over the assessment period.

Preclinical Imaging Market - Competitive Analysis

Highly competitive, the preclinical imaging market appears fragmented due to the presence of several notable players. To gain a larger competitive share in the market, players adopt strategies such as mergers & acquisitions, collaboration, expansion, and product & technology launch. Industry players make substantial investments to drive R&D and expansion plans. R&D investments help them to better their imaging agents, and expansion investment helps them to increase their global footprints.

Preclinical Imaging Market Major Players:

Players leading the global preclinical imaging market include Bruker Corporation (US), MR Solutions (UK), PerkinElmer (US), Fujifilm Holdings Corporation (Japan), Milabs BV (The Netherlands), Mediso Ltd. (Hungary), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Aspect Imaging (Israel), and Trifoil Imaging (US), among others.

Preclinical Imaging Industry/Innovation/Related News:

May 29, 2020 ---- Avid Radiopharmaceuticals (the US), a wholly-owned subsidiary of Eli Lilly and Company, announced receiving the FDA approval for its imaging drug Tauvid. Tauvid is the first drug to help image a specific characteristic of Alzheimer’s disease in the brain known as tau pathology. Avid develops new molecular imaging agents capable of changing the medical management of significant chronic human diseases.

Tauvid, an IV injection, is approved for adults with cognitive impairment and are being evaluated for Alzheimer’s. Tauvid is a radioactive diagnostic agent indicated to use in positron emission tomography imaging of the brain. The new agent is used to assess the density and distribution of aggregated tau neurofibrillary tangles (NFTs), a primary signal of Alzheimer’s disease.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

...TOC Continued

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Healthcare Industry Related Reports

Oncology Information Systems Market Research Report – Global Forecast till 2023

Medical Carts Market Research Report - Forecast to 2023

Urinary Catheters Market Research Report - Forecast to 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 06468459312

Release ID: 88963878